Cara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cara Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.37 | $-0.27 | -37.0 % |
Mar 2024 | 2024-05-13 | $-0.56 | $-0.40 | -40.0 % |
Dec 2023 | 2024-03-04 | $-0.59 | $-0.41 | -43.9 % |
Sep 2023 | 2023-11-13 | $-0.52 | $-0.52 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $991.00K | $1.17M | -15.3 % |
Mar 2024 | 2024-05-13 | $2.13M | $1.69M | 26.3 % |
Dec 2023 | 2024-03-04 | $3.00M | $9.42M | -68.1 % |
Sep 2023 | 2023-11-13 | $4.87M | $9.95M | -51.1 % |
Cara Therapeutics (CARA) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.37, which missed the estimate of $-0.27.
The Actual Revenue was $991K, which missed the estimate of $1.2M.
Browse earnings estimates, EPS, and revenue on all stocks.